Overall survival Kaplan-Meier curves of metastatic breast cancer... | Download Scientific Diagram
Overall Survival Analysis | MBC | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer | Breast Cancer Research | Full Text
VisualAbstract: Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer | 2 Minute Medicine
Overall survival (OS) in patients with HER2-positive metastatic breast... | Download Scientific Diagram
Comparison of the clinicopathological characteristics and prognosis between Chinese patients with breast cancer with bone‑only and non‑bone‑only metastasis
Intensity of metastasis screening and survival outcomes in patients with breast cancer | Scientific Reports
De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995 - eClinicalMedicine
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site | Anticancer Research
Overall survival (OS) in patients with HER2-positive metastatic breast... | Download Scientific Diagram
Breast Cancer Survival Rates: Prognosis by Age, Race & More
Overall survival. Overall survival of patients with bone metastases... | Download Scientific Diagram
De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China - The Breast
Impact of Primary Site Surgery on Survival of Patients with de novo St | CMAR
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium - Annals of Oncology
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? | British Journal of Cancer
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel - Clinical Breast Cancer
CELLSEARCH® | Significance of CTCs | Clinical Relevance
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine | Scientific Reports
Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer | Scientific Reports
